Sheldon G. Gilgore, M.D.; Joseph J. Rupp, M.D. (Associate); Lawrence W. Drew, M.D.
This content is PDF only. Please click on the PDF icon to access.
Salicylates, like insulin and tolbutamide, effectively lower the elevated blood sugar levels of diabetics, but unlike insulin they do not significantly alter the blood glucose levels of normal subjects. In view of this important difference in mode of action it was decided to study not only changes in blood glucose but variations in the plasma nonesterified fatty acids (NEFA) after an intravenous infusion of sodium salicylate with the knowledge that insulin and the sulfonyl urea drugs produce a lowering of NEFA that parallels the lowering of the blood glucose. Five grams of sodium salicylate were infused intravenously into groups of
Gilgore SG, Rupp JJ, Drew LW. The Influence of Salicylates on Aspects of Carbohydrate and Lipid Metabolism.. Ann Intern Med. ;60:333. doi: 10.7326/0003-4819-60-2-333_1
Download citation file:
Published: Ann Intern Med. 1964;60(2_Part_1):333.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use